Screening for hereditary haemochromatosis should be implemented now
BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7228.183 (Published 15 January 2000) Cite this as: BMJ 2000;320:183- Katrina Allen (allenk@cryptic.rch.unimelb.edu.au), paediatric gastroenterologist,
- Robert Williamson, director
- Murdoch Institute, Royal Children's Hospital, Parkville, 3052, Victoria, Australia
EDITOR—The editorial by Haddow and Bradley on population screening for haemochromatosis concludes that now is too early to start population screening because of uncertainties about the proportion of homozygotes who will express symptoms of the disease.1 Haemochromatosis has been recognised as a clinical entity for over 150 years, but the gene that is mutated was not identified until 1996. Clinical haemochromatosis, defined by the presence of abnormal serum iron variables, has consistently been estimated to affect …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.